Wraparound for High-risk Families with Substance Use Disorders: Examining Family, Child, and Parent Outcomes

Summary

The investigators propose a Hybrid Type 1 effectiveness-implementation quasi-experimental trial. Participants are drawn from two different communities contemporaneously. The intervention participants in one community receive a Wraparound intervention. Comparison group participants drawn from a second matched community receive treatment as usual. With this design, the investigators aim to study outcomes associated with the intervention as well as explore important facilitators and barriers associated with the implementation and other factors associated with reach / participation, engagement and acceptability.

Wraparound is a structured 12-month family-driven "process" that is guided by family goals, includes a team of supports to wrap around families, and coordinates care for families. Wraparound has been primarily delivered and tested with families of older-age children with severe emotional and behavioral needs in an attempt to prevent residential placement. The investigators are interested in testing the model in a sample of families (n=160) affected by substance use disorders who have children placed outside the home or are at risk of such placement. The investigators hypothesize that families receiving Wraparound will obtain better parenting and family functioning outcomes (primary outcome); child safety, permanency, and well-being; and parental recovery than families receiving treatment as usual. The investigators will also explore factors associated with higher levels of engagement and outcomes, including family characteristics, referral sources and hand-off, and similarly, explore barriers and facilitators associated with engagement and/or outcomes.

Conditions

• Substance-Related Disorders
• Depression
• Stress Disorders, Post-Traumatic
• Child Abuse
• Child Neglect

Interventions

BEHAVIORAL

Wraparound

Wraparound is a 12-month family-driven intensive care coordination model.

Sponsors & Collaborators

• Dartmouth College

  collaborator OTHER

• Children's Bureau - Administration for Children and Families

  collaborator OTHER

• Mathematica Policy Research, Inc.

  collaborator OTHER

• Dartmouth-Hitchcock Medical Center

  lead OTHER

Principal Investigators

• Erin R Barnett, PhD · Dartmouth-Hitchcock Medical Center

Study Design

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2020-11-16

Primary Completion

2024-09-30

Completion

2024-09-30

Countries

• United States

Study Locations